World Federation of Hemophilia /LinkedIn
Feb 4, 2026, 17:28
Join the World Federation of Hemophilia at EAHAD 2026
World Federation of Hemophilia – WFH shared a post on LinkedIn:
“Join the World Federation of Hemophilia at EAHAD 2026 and connect with our work on gene therapy, gene editing, von Willebrand disease, and shared decision-making in Bleeding Disorders.
Oral presentation
WFH, EAHAD, and EHC: Best practice recommendations for implementing shared decision-making in hemophilia
Friday, February 6 | 8:30 a.m. | Session OR10
Posters on display (Level 0)
- The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025 (PO067)
- Enhancing Understanding of Gene Editing in Hemophilia: A New WFH Initiative (PO176)
- Global disparities in von Willebrand disease diagnosis and management: an analysis using the WFH World Bleeding Disorders Registry (PO228)
February 4 – 6, 2026 | Poster area, Level 0
We invite you to stop by and learn more.”
More posts about World Federation of Hemophilia.
-
Sep 30, 2026, 01:52Javed Anees: DADA2 – When a Young Stroke Is More Than a Stroke
-
Sep 30, 2026, 01:51How a Venous Thrombus Becomes Revascularized – ISTH
-
Sep 29, 2026, 22:45Victor Agunyego: Paracetamol – The Most Common Drug We Underestimate
-
Sep 29, 2026, 22:42Nova Sinclair: Advancing the Future of Hematology – Meet Our 2027 Organizing Committee
-
Sep 29, 2026, 22:41Lorenz Räber: Intracoronary Imaging in PCI – Why, When, How, and Which Modality?
-
Sep 29, 2026, 22:31Selma Turkovic: Pleased to Deliver the Opening Presentation at Kingston Hospital
-
Sep 29, 2026, 22:31Miguel Teran: Ultrasound and Simulation in Arterial Blood Sampling
-
Sep 29, 2026, 22:28Mohammad Refaei: Navigating Your Career in Hematology From Training to Practice
-
Sep 29, 2026, 22:27Matteo Foschi: 10 Clinical Pearls for Antithrombotic Therapy in Secondary Stroke Prevention